TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
6 hedge funds and large institutions have $4.37M invested in TIANYIN PHARMACEUTICAL in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
53% more capital invested
Capital invested by funds: $2.86M → $4.37M (+$1.5M)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$8.05K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$4.42K |
| 3 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
+$1.32K |
Top Sellers
| 1 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
-$3.23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $3.98M | +$1.32K | +2,000 | +0% |
|
|
2
Renaissance Technologies
New York
| $308K | +$8.05K | +12,200 | +3% |
|
|
CCB
3
Cutter & Co Brokerage
Ballwin,
Missouri
| $52K | -$3.23K | -4,900 | -7% |
|
|
RIM
4
Regent Investment Management
Louisville,
Kentucky
| $24K | – | – | – |
|
|
U
5
UBS
Zurich,
Switzerland
| $7K | +$4.42K | +6,701 | +219% |
|
|
FA
6
Financial Advantage
Columbia,
Maryland
| $1K | – | – | – |
|
TPI Hedge Fund Activity: Q3 2013 in Review
6 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q3 2013, worth a combined $4.37M — up 53% from $2.86M a quarter earlier.
Fund positioning in TPI was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $8.05K. The largest seller was Cutter & Co Brokerage, cutting an estimated $3.23K.
- 6 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $4.37M of TIANYIN PHARMACEUTICAL stock for Q3 2013, up 53% quarter-over-quarter.
- 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q3 2013 and 0 closed out.
- The largest TIANYIN PHARMACEUTICAL buyer in Q3 2013 was Renaissance Technologies, an estimated $8.05K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q3 2013 was Cutter & Co Brokerage, an estimated $3.23K sold.
Based on aggregated 13F filings for Q3 2013.